By Julie Steenhuysen CHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was too good to be true. The study, ... More »
(Reuters) - Baxter International Inc said it will stop developing a drug for treating mild to moderate Alzheimer's disease after a late-stage study showed it failed to reduce the decline of cognitive functions and preserve functional abilities... More »
By Julie Steenhuysen CHICAGO (Reuters) - In a move to shore up its lead in Alzheimer's diagnostics, Eli Lilly and Co on Wednesday said it will acquire two imaging agents from Siemens designed to light up brain deposits of tau, an Alzheimer'... More »
By Susan Heavey WASHINGTON (Reuters) - Deaths and the risk of dying from Alzheimer's disease have risen significantly in the United States during the last decade, according to two reports released on Tuesday. The trend comes as scientists and ... More »